HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey I Weitz Selected Research

N(4)-oleylcytosine arabinoside

5/2018Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with bioprosthetic valves.
1/2018Reversal agents for non-vitamin K antagonist oral anticoagulants.
1/2017Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
11/2015Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey I Weitz Research Topics

Disease

112Hemorrhage
02/2024 - 07/2003
96Venous Thromboembolism
01/2024 - 04/2003
90Thrombosis (Thrombus)
05/2024 - 05/2002
35Atrial Fibrillation
02/2024 - 04/2004
30Stroke (Strokes)
02/2024 - 04/2002
29Neoplasms (Cancer)
01/2023 - 02/2004
24Venous Thrombosis (Deep-Vein Thrombosis)
01/2024 - 05/2003
17Thromboembolism
08/2022 - 09/2003
14Acute Coronary Syndrome
01/2019 - 02/2002
11Pulmonary Embolism
09/2023 - 01/2004
11Myocardial Infarction
01/2020 - 04/2002
10Sepsis (Septicemia)
01/2023 - 12/2004
9COVID-19
12/2021 - 01/2020
8Inflammation (Inflammations)
11/2022 - 03/2002
8Peripheral Arterial Disease
09/2022 - 01/2019
8Thrombocytopenia (Thrombopenia)
01/2017 - 08/2004
7Intracranial Hemorrhages (Intracranial Hemorrhage)
11/2023 - 01/2012
7Embolism (Embolus)
10/2022 - 04/2012
6Heart Diseases (Heart Disease)
01/2019 - 01/2003
4Polyps
05/2024 - 01/2021
4Renal Insufficiency (Renal Failure)
02/2024 - 09/2018
4Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 09/2002
4Body Weight (Weight, Body)
10/2018 - 09/2016
4Neoplasm Metastasis (Metastasis)
11/2008 - 02/2004
3Vascular Diseases (Vascular Disease)
03/2022 - 01/2019
3Critical Illness (Critically Ill)
12/2021 - 01/2021
3Factor XI Deficiency (Hemophilia C)
04/2021 - 05/2016
3Vascular System Injuries
01/2020 - 12/2006
3Ischemic Stroke
01/2019 - 03/2014
3Unstable Angina
11/2016 - 09/2002
3Osteoporosis
02/2012 - 07/2006
2Chronic Kidney Failure (Chronic Renal Failure)
01/2024 - 12/2021
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2023 - 01/2019
2Fibrosis (Cirrhosis)
11/2023 - 12/2021
2Anemia
12/2021 - 01/2021
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2021 - 08/2018
2Pneumonia (Pneumonitis)
12/2021 - 05/2020

Drug/Important Bio-Agent (IBA)

121AnticoagulantsIBA
02/2024 - 05/2002
43Warfarin (Coumadin)FDA LinkGeneric
11/2023 - 04/2003
40RivaroxabanIBA
11/2023 - 04/2012
37Vitamin KFDA Link
02/2024 - 04/2004
32ThrombinFDA Link
01/2023 - 04/2002
29Heparin (Liquaemin)FDA LinkGeneric
12/2021 - 05/2002
23edoxabanIBA
09/2022 - 09/2010
21apixabanIBA
11/2023 - 12/2011
21DabigatranFDA Link
01/2022 - 01/2009
20Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2023 - 04/2002
18Enoxaparin (Lovenox)FDA LinkGeneric
05/2024 - 09/2002
16FibrinIBA
05/2024 - 03/2002
16Factor XI (Plasma Thromboplastin Antecedent)IBA
02/2024 - 04/2011
14Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2023 - 09/2002
13fibrin fragment D (D-dimer)IBA
12/2021 - 05/2003
12Factor Xa InhibitorsIBA
01/2019 - 03/2005
12Fondaparinux (Arixtra)FDA Link
03/2017 - 09/2002
10AntithrombinsIBA
12/2021 - 02/2002
9Factor XII (Hageman Factor)IBA
05/2024 - 04/2011
8histidine-rich proteinsIBA
05/2024 - 04/2011
7Thromboplastin (Tissue Factor)IBA
09/2010 - 08/2003
6CreatinineIBA
10/2022 - 08/2016
6Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2022 - 02/2012
6Cell-Free Nucleic AcidsIBA
12/2021 - 08/2012
5PolyphosphatesIBA
05/2024 - 12/2017
5Biomarkers (Surrogate Marker)IBA
11/2022 - 08/2012
5Blood Coagulation Factors (Coagulation Factor)IBA
08/2022 - 11/2010
5Fibrinogen (Factor I)FDA Link
12/2021 - 11/2010
5Dalteparin (Dalteparin Sodium)FDA Link
12/2021 - 02/2018
5Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2021 - 08/2003
5Clopidogrel (Plavix)FDA Link
01/2019 - 07/2014
5Factor Xa (Coagulation Factor Xa)IBA
10/2018 - 03/2005
4Hemoglobins (Hemoglobin)IBA
12/2021 - 01/2018
4Protein CIBA
12/2021 - 12/2004
4N(4)-oleylcytosine arabinosideIBA
05/2018 - 11/2015
4idarucizumabIBA
05/2017 - 07/2015
4Antisense OligonucleotidesIBA
05/2016 - 03/2014
3Factor XIa (Coagulation Factor XIa)IBA
01/2023 - 01/2020
3LubricantsIBA
12/2022 - 12/2019
3TicagrelorIBA
03/2022 - 07/2014
3ZincIBA
01/2021 - 03/2013
3Proteins (Proteins, Gene)FDA Link
12/2019 - 06/2004
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2018 - 08/2016
3pro-brain natriuretic peptide (1-76)IBA
01/2018 - 09/2016
3Deoxyribonucleases (DNase)FDA Link
08/2015 - 09/2014
3ximelagatran (Exanta)IBA
01/2005 - 04/2004
2osocimabIBA
02/2024 - 01/2020
2CholesterolIBA
11/2023 - 01/2019
2Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
09/2023 - 01/2020
2Endothelial Protein C ReceptorIBA
12/2021 - 11/2013
2abelacimabIBA
12/2021 - 11/2021
2Histones (Histone)IBA
12/2021 - 09/2014

Therapy/Procedure

70Therapeutics
02/2024 - 08/2003
10Catheters
01/2024 - 10/2009
7Knee Replacement Arthroplasty (Total Knee Replacement)
12/2021 - 01/2014
7Secondary Prevention
12/2019 - 01/2005
6Percutaneous Coronary Intervention
01/2019 - 09/2002
5Duration of Therapy
07/2022 - 09/2016
2Polypharmacy
02/2024 - 01/2018
2Renal Dialysis (Hemodialysis)
02/2024 - 12/2021
2Central Venous Catheters
01/2023 - 08/2019
2Drug Tapering
01/2022 - 09/2016
2Drug Therapy (Chemotherapy)
12/2021 - 02/2004